Edward T. Mathers

Insider Reports History

Location
C/O Medimmune, Inc., One Medimmune Way, Gaithersburg, MD
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward T. Mathers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7.69M $146M $19.00 Jun 28, 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24.5M $109M $4.45 Jul 17, 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1.09M $61.1M $56.00 Apr 22, 2024 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Common Stock 3.61M $38.6M $10.69 Sep 16, 2024 Indirect
RHYTHM PHARMACEUTICALS, INC. Director Common Stock 7K $413K $58.97 Jun 18, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Common Stock 5.77K $340K $58.97 Jun 18, 2025 Indirect
OnKure Therapeutics, Inc. Director Class A Common Stock 11.4K $30K $2.63 Sep 30, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Restricted Stock Units 4.71K $0 $39.10 Jun 24, 2025 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 Oct 2, 2025 Indirect
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 45K Jun 11, 2025 Direct
SYNLOGIC, INC. Director Stock Option (right to buy) 30K Jun 22, 2023 Direct
Inozyme Pharma, Inc. Director Stock Option (right to buy) 28K Jun 18, 2024 Direct
Senti Biosciences, Inc. Director Stock Option (Right to Buy) 22K Jun 25, 2025 Direct
Mirum Pharmaceuticals, Inc. Director Stock Option (right to buy) 17K Jun 2, 2022 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Stock option (right to buy) 16K Jun 5, 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7.65K May 28, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 7.04K Jun 24, 2025 Direct
Akouos, Inc. Director Stock Option (right to buy) 0 Dec 1, 2022 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 $2.96 Jun 28, 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 Oct 2, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 Oct 2, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 Oct 2, 2025 Indirect

Insider Reports Filed by Edward T. Mathers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEUE NeueHealth, Inc. Oct 2, 2025 23 $9.58 4 Oct 6, 2025 Director, 10%+ Owner
OKUR OnKure Therapeutics, Inc. Sep 30, 2025 1 $0 4 Oct 2, 2025 Director
OKUR OnKure Therapeutics, Inc. Jun 30, 2025 1 $0 4 Jul 2, 2025 Director
SNTI Senti Biosciences, Inc. Jun 25, 2025 1 $0 4 Jun 27, 2025 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 24, 2025 2 $0 4 Jun 26, 2025 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 18, 2025 2 $0 4 Jun 23, 2025 Director
TRVI Trevi Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director
MBX MBX Biosciences, Inc. Jun 5, 2025 1 $0 4 Jun 6, 2025 Director, 10%+ Owner
OKUR OnKure Therapeutics, Inc. May 28, 2025 1 $0 4 May 30, 2025 Director
OKUR OnKure Therapeutics, Inc. Mar 31, 2025 1 $0 4 Apr 2, 2025 Director
SNTI Senti Biosciences, Inc. Mar 7, 2025 1 $0 4 Mar 11, 2025 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Director
NEUE NeueHealth, Inc. Oct 1, 2024 2 $0 4 Oct 3, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 16, 2024 5 $8M 4 Sep 17, 2024 Director, 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 1 $0 4 Sep 13, 2024 Director, 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director, 10%+ Owner
SNTI Senti Biosciences, Inc. Jul 10, 2024 1 $0 4 Jul 12, 2024 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 21, 2024 2 $0 4 Jun 25, 2024 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
INZY Inozyme Pharma, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
TRVI Trevi Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
KRRO Korro Bio, Inc. Apr 22, 2024 1 $1M 4 Apr 24, 2024 10%+ Owner
NEUE NeueHealth, Inc. Apr 8, 2024 2 $0 4 Apr 10, 2024 10%+ Owner
BHG Bright Health Group Inc. Dec 19, 2023 1 $0 4 Dec 21, 2023 10%+ Owner
FREQ Korro Bio, Inc. Nov 3, 2023 0 $0 3 Nov 7, 2023 10%+ Owner
BHG Bright Health Group Inc. Oct 31, 2023 1 $0 4 Nov 2, 2023 10%+ Owner
BHG Bright Health Group Inc. Sep 15, 2023 1 $0 4 Sep 19, 2023 10%+ Owner
BHG Bright Health Group Inc. Aug 11, 2023 1 $0 4 Aug 15, 2023 10%+ Owner
SVRA Savara Inc Jul 17, 2023 1 $1M 4 Jul 19, 2023 10%+ Owner
TRVI Trevi Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
SYBX SYNLOGIC, INC. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
SNTI Senti Biosciences, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
INZY Inozyme Pharma, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
RPHM Reneo Pharmaceuticals, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Mar 2, 2023 1 $0 4 Mar 6, 2023 Director
OBSV ObsEva SA Jan 1, 2023 0 $0 3 Jan 3, 2023 Director
AKUS Akouos, Inc. Dec 1, 2022 1 $0 4 Dec 2, 2022 Director
BHG Bright Health Group Inc. Oct 17, 2022 2 $138M 4 Oct 19, 2022 10%+ Owner
SNTI Senti Biosciences, Inc. Jul 13, 2022 1 $0 4 Jul 15, 2022 Director
AKUS Akouos, Inc. Jun 23, 2022 1 $0 4 Jun 27, 2022 Director
TRVI Trevi Therapeutics, Inc. Jun 23, 2022 1 $0 4 Jun 23, 2022 Director
INZY Inozyme Pharma, Inc. Jun 10, 2022 1 $0 4 Jun 14, 2022 Director
SYBX SYNLOGIC, INC. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
SNTI Senti Biosciences, Inc.\ Jun 8, 2022 0 $0 3 Jun 15, 2022 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
RPHM Reneo Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 2 $7.5M 4 Apr 13, 2022 Director
BHG Bright Health Group Inc. Jan 3, 2022 0 $0 3 Jan 5, 2022 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $20M 4 Jun 30, 2021 10%+ Owner
AKUS Akouos, Inc. Jun 24, 2021 1 $0 4 Jun 25, 2021 Director
BHG Bright Health Group Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
INZY Inozyme Pharma, Inc. Jun 23, 2021 1 $0 4 Jun 24, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner
TRVI Trevi Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
SYBX SYNLOGIC, INC. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 9, 2021 1 $0 4/A Jun 16, 2021 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Jun 9, 2011 1 $0 4 Jun 11, 2021 Director